Expression of beta-actin during progression of mouse skin tumors.
Expression of beta-actin during progression of mouse skin tumors.
复制标题
小鼠皮肤肿瘤进展过程中β-肌动蛋白的表达。
DOI:
10.1093/carcin/10.8.1439
复制
发表时间:
1989
期刊:
影响因子:
4.7
通讯作者:
Bowden,GT
中科院分区:
文献类型:
--
作者:
Ostrowski,LE;Krieg,P;Finch,J;Cress,AE;Nagle,RB;Bowden,GT
Recombinant DNA techniques have been employed to isolate sequences that are over-expressed during multi-stage carcinogenesis in the mouse skin. One of these six cDNA sequences, mal-4, detected 1.9-kb transcripts that were expressed at levels 10-fold higher in squamous cell carcinomas (SCCs) in comparison to normal epidermis. A full-length cDNA for mal-4 was obtained from a λgt10 cDNA library made from an SCC-producing cell line, PDVC57. DNA sequencing of 1300 out of 1900 bp of the mal-4 cDNA and searching of Genbank showed >95% DNA sequence similarity to mouseβ-actin over the entire cDNA and >98% similarity over the 3' untranslated region, which is unique to the various isoforms of actins. Southern analysis showed no amplification or rearrangement of theβ-actin gene had occurred during tumor progression. The RNA:RNA hybrid protection assay was utilized to screen for the expression of mutatedβ-actin(s) in mouse skin tumors. No evidence for mutation was obtained in any of the tumors examined. Fluorescence microscopy of tumor sections stained with rhodamine-conjugated phalloidin showed a peripheral pattern of F-actin localization with no gross differences between papillomas and carcinomas. Approximately equal amounts ofβ-actin were observed following two-dimensional gel electrophoresis of proteins extracted from normal epidermis, papillomas or SCCs, indicating that the over-expression ofβ-actin RNA in SCCs did not result in an increased steadystate level ofβ-actin protein. These results suggest that alterations in actin metabolism accompany tumor progression.